Assessing arterial stiffness and heart disease risk using a novel technology
Official title: Cardio Alpha - Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment
Run by HJN Sverige AB/Neko Health · NCT06984211 · Data updated 2026-11-12
This study is testing a new, no-touch technology to measure how stiff your arteries are and see if it can help figure out your risk for heart disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 8000 (estimated) |
| Sponsor | HJN Sverige AB/Neko Health Industry-sponsored |
| Locations | 3 sites (Stockholm and 2 other locations) |
| Status | Recruiting |
| Started | February 1, 2023 |
| Main results expected | February 1, 2026 |
| Study ends | February 1, 2026 |
| Registry record updated | May 22, 2025 |
| Trial ID | NCT06984211 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult patients within the regular healthcare flow at the investigational sites who can provide informed consent.
✕Probably not a fit
Patients with cognitive impairments or severe terminal diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical investigation evaluates a new contactless technology for measuring arterial stiffness and its potential in assessing cardiovascular disease risk. The study focuses on a primary care cohort, utilizing a laser-radar-based vibrometer to gather data on arterial stiffness and cardiovascular health. Participants will undergo various assessments, including blood pressure measurements and ECG, with additional investigations for those at higher risk of cardiovascular issues. The aim is to improve the precision of cardiovascular disease risk assessment through a multi-modal approach.
Why it matters
Potential benefit: If successful, this study could lead to more accurate assessments of cardiovascular disease risk, potentially improving patient outcomes.
How similar studies have gone: While the approach is innovative, similar studies have shown promise in assessing cardiovascular risk using non-invasive methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation. * Patients with signed informed consent Exclusion criteria: * Cognitive impairment * Patients unable to understand the oral and written study information in Swedish or English * Other severe disorder or terminal disease, e.g. infection/sepsis, severe COPD or metastatic cancers. * Patients unable to provide an informed consent
Where it's running
-
Atrium Health Care Centre
Stockholm, Sweden Recruiting -
Neko Health Centre, Regeringsgatan
Stockholm, Sweden Recruiting -
Neko Health Centre, Sibyllegatan
Stockholm, Sweden Recruiting
Study contacts
- Principal investigator: Henrik Hellqvist, MD — Neko Health AB
- Study coordinator: Mattias Windå, MSc
- Email: mattias@nekohealth.com
- Phone: +46703169040
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
-
Longitudinal Assessment of Cardiac MRI Microstructure in Patients and Healthy People
This study tests advanced, non-contrast and extended clinical cardiac MRI techniques to see how heart tissue features differ between people with heart disease and healthy individuals.
-
AI-based assessment of heart function using ECG wearable monitors
This study tests if a new AI tool using a wearable heart monitor can accurately check heart function in people with heart failure compared to traditional heart scans.
-
Development of advanced MRI techniques for heart disease assessment
This study is testing new MRI techniques to see how heart tissue differs between people with heart disease and healthy individuals to improve heart assessments.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.